Crispr sees gene therapy milestone in Europe – Seeking Alpha
|
Crispr sees gene therapy milestone in Europe
Seeking Alpha Crispr sees gene therapy milestone in Europe. Apr. 16, 2018 3:10 AM ET |By: Yoel Minkoff, SA News Editor. Humans are set to be genetically modified for the first time in Europe after regulators gave the go ahead to trial Crispr Therapeutics’ (NASDAQ … |
Chemical & Engineering News |
Inventor, chemist, and CRISPR craftsman: Inside David Liu’s evolution workshop
Chemical & Engineering News David R. Liu is an inventor on a winning streak. As a young chemist, he quickly mastered techniques for studying life’s most complex molecules and then turned to altering the building blocks of life itself. He repurposed the genetic code of DNA to … |
|
Study of promising targeted drug delivery scaffold
Science Daily I’m excited to see where it goes. The study builds on Tullman-Ercek’s earlier work, which found that a single amino acid mutation in the same MS2 bacteriophage scaffold drastically changed its size. Tullman-Ercek serves as a faculty member within … |
|
Rounds Report: Nephros And Protalix Bulls Charged Ahead While Crispr Insiders Built Shares
Seeking Alpha After a robust rally for the week, investors closed out the Friday’s session with skittish sentiments. Notable stocks under our coverage defied the overall market downtrend include Nephros, Crispr, and. With improved prospects, there is much room for … |